{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Pancreatic+Insufficiency&page=2", "query": { "condition": "Pancreatic Insufficiency", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Pancreatic+Insufficiency&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-06-11T00:10:50.056Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00297167", "title": "Study to Evaluate the Safety and Efficacy of EUR-1008 (APT-1008) Pancreatic Enzyme Product in Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Cystic Fibrosis", "Exocrine Pancreatic Insufficiency" ], "interventions": [ { "name": "EUR-1008 (APT-1008)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Forest Laboratories", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "7 Years", "maximum_age": null, "sex": "ALL", "summary": "7 Years and older" }, "enrollment_count": 34, "start_date": "2006-05", "completion_date": "2006-11", "has_results": true, "last_update_posted_date": "2017-03-16", "last_synced_at": "2026-06-11T00:10:50.056Z", "location_count": 1, "location_summary": "Tyler, Texas", "locations": [ { "city": "Tyler", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00297167" }, { "nct_id": "NCT07285863", "title": "A Study Of Effect Of Secretin For In Injection (Chirostim) On Pancreatic Fluid Composition In Healthy Subjects", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Exocrine Pancreatic Insufficiency", "Chronic Pancreatitis" ], "interventions": [ { "name": "Secretin (human synthetic) - ChiRhoClin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 24, "start_date": "2026-03-11", "completion_date": "2028-03", "has_results": false, "last_update_posted_date": "2026-04-28", "last_synced_at": "2026-06-11T00:10:50.056Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT07285863" }, { "nct_id": "NCT01917708", "title": "Bone Marrow Transplant With Abatacept for Non-Malignant Diseases", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Hurler Syndrome", "Fanconi Anemia", "Glanzmann Thrombasthenia", "Wiskott-Aldrich Syndrome", "Chronic Granulomatous Disease", "Severe Congenital Neutropenia", "Leukocyte Adhesion Deficiency", "Shwachman-Diamond Syndrome", "Diamond-Blackfan Anemia", "Dyskeratosis-congenita", "Chediak-Higashi Syndrome", "Severe Aplastic Anemia", "Thalassemia Major", "Hemophagocytic Lymphohistiocytosis", "Sickle Cell Disease" ], "interventions": [ { "name": "Abatacept", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "21 Years", "sex": "ALL", "summary": "Up to 21 Years" }, "enrollment_count": 10, "start_date": "2014-01", "completion_date": "2019-09-19", "has_results": false, "last_update_posted_date": "2019-12-26", "last_synced_at": "2026-06-11T00:10:50.056Z", "location_count": 1, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01917708" }, { "nct_id": "NCT00690820", "title": "Study Investigating a Delayed-Release Pancrelipase in Patients With Pancreatic Exocrine Insufficiency (PEI) Due to Cystic Fibrosis (CF)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Cystic Fibrosis", "Pancreatic Exocrine Insufficiency" ], "interventions": [ { "name": "Pancrelipase Delayed Release", "type": "DRUG" }, { "name": "Placebo Comparator", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Solvay Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "7 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "7 Years to 11 Years" }, "enrollment_count": 17, "start_date": "2008-06", "completion_date": "2008-12", "has_results": true, "last_update_posted_date": "2010-06-02", "last_synced_at": "2026-06-11T00:10:50.056Z", "location_count": 10, "location_summary": "Iowa City, Iowa • Louisville, Kentucky • Boston, Massachusetts + 6 more", "locations": [ { "city": "Iowa City", "state": "Iowa" }, { "city": "Louisville", "state": "Kentucky" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Ann Arbor", "state": "Michigan" }, { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT00690820" }, { "nct_id": "NCT02734810", "title": "SIMPLICITY: Studying Impacts on Malabsorption With Liprotamase in Cystic Fibrosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Exocrine Pancreatic Insufficiency", "Cystic Fibrosis" ], "interventions": [ { "name": "Liprotamase Powder for Oral Solution", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Anthera Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "28 Days", "maximum_age": null, "sex": "ALL", "summary": "28 Days and older" }, "enrollment_count": 15, "start_date": "2016-06", "completion_date": "2017-03", "has_results": true, "last_update_posted_date": "2018-05-11", "last_synced_at": "2026-06-11T00:10:50.056Z", "location_count": 21, "location_summary": "Little Rock, Arkansas • Orange, California • Aurora, Colorado + 17 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Orange", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Altamonte Springs", "state": "Florida" }, { "city": "Hollywood", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02734810" }, { "nct_id": "NCT01851694", "title": "Beta-cell Response to Incretin Hormones in Cystic Fibrosis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cystic Fibrosis", "Pancreatic Insufficiency" ], "interventions": [ { "name": "GLP-1", "type": "DRUG" }, { "name": "GIP", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Pennsylvania", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 45, "start_date": "2013-05", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2026-01-14", "last_synced_at": "2026-06-11T00:10:50.056Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT01851694" }, { "nct_id": "NCT01476995", "title": "Prognostic Indicators as Provided by the EPIC ClearView", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Coronary Artery Disease", "Congestive Heart Failure", "Valvular Heart Disease", "Atrial Fibrillation", "Hypertension", "Pyelonephritis", "Acute Renal Failure", "Renal Failure", "Viral Hepatitis", "Alcoholic Hepatitis", "Steatohepatitis", "Cirrhosis", "Asthma", "COPD", "Bronchitis", "Emphysema", "Pneumonia", "Inflammatory Bowel Disease", "Crohn's Disease", "Ulcerative Colitis", "Diverticulitis", "Peptic Ulcer Disease", "Irritable Bowel Syndrome", "Cholecystitis", "Pancreatitis", "Malabsorption Disorders", "Celiac Sprue", "Diabetes" ], "interventions": [], "intervention_types": [], "sponsor": "Epic Research & Diagnostics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 353, "start_date": "2010-09", "completion_date": "2011-06", "has_results": false, "last_update_posted_date": "2011-11-22", "last_synced_at": "2026-06-11T00:10:50.056Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT01476995" }, { "nct_id": "NCT00981214", "title": "Study of Pancreatic Enzyme Product in Pediatric Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Cystic Fibrosis", "Exocrine Pancreatic Insufficiency" ], "interventions": [ { "name": "EUR-1008 (APT-1008)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Forest Laboratories", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "7 Years", "sex": "ALL", "summary": "Up to 7 Years" }, "enrollment_count": 19, "start_date": "2006-05", "completion_date": "2006-09", "has_results": true, "last_update_posted_date": "2017-03-16", "last_synced_at": "2026-06-11T00:10:50.056Z", "location_count": 14, "location_summary": "Birmingham, Alabama • Los Angeles, California • Oakland, California + 11 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "Oakland", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00981214" }, { "nct_id": "NCT00662675", "title": "A Study of the Efficacy and Tolerability of Pancrelipase Microtablet (MT) Capsules for the Treatment of Cystic Fibrosis-dependent Exocrine Pancreatic Insufficiency", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Exocrine Pancreatic Insufficiency", "Steatorrhea", "Malabsorption Syndromes", "Cystic Fibrosis" ], "interventions": [ { "name": "Pancrease MT 10.5, or MT 21", "type": "DRUG" }, { "name": "Placebo for Pancrease MT 10.5 or MT 21", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Johnson & Johnson Pharmaceutical Research & Development, L.L.C.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "7 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "7 Years to 60 Years" }, "enrollment_count": 40, "start_date": "2008-08", "completion_date": "2009-02", "has_results": true, "last_update_posted_date": "2014-05-09", "last_synced_at": "2026-06-11T00:10:50.056Z", "location_count": 10, "location_summary": "Long Beach, California • Los Angeles, California • Orlando, Florida + 7 more", "locations": [ { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Orlando", "state": "Florida" }, { "city": "Louisville", "state": "Kentucky" }, { "city": "Las Vegas", "state": "Nevada" } ], "official_url": "https://clinicaltrials.gov/study/NCT00662675" }, { "nct_id": "NCT01652157", "title": "Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Fibrosing Colonopathy" ], "interventions": [ { "name": "ULTRESA", "type": "BIOLOGICAL" }, { "name": "PANCREAZE", "type": "BIOLOGICAL" }, { "name": "CREON", "type": "BIOLOGICAL" }, { "name": "ZENPEP", "type": "BIOLOGICAL" }, { "name": "other non-sponsor pancreatic enzyme replacement therapy", "type": "BIOLOGICAL" }, { "name": "PERTZYE", "type": "BIOLOGICAL" }, { "name": "No pancreatic enzyme replacement therapy", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "AbbVie", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "0 Months", "maximum_age": "99 Years", "sex": "ALL", "summary": "0 Months to 99 Years" }, "enrollment_count": 17, "start_date": "2012-07-31", "completion_date": "2020-04-08", "has_results": false, "last_update_posted_date": "2021-03-22", "last_synced_at": "2026-06-11T00:10:50.056Z", "location_count": 123, "location_summary": "Birmingham, Alabama • Anchorage, Alaska • Phoenix, Arizona + 102 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01652157" } ] }